ESACT UK Next Week at the Oxford Belfry

Download News

Come and join us at the 27th annual ESACT UK meeting will be held next week 11 – 12 January 2017 at the Oxford Belfry.

Programme sessions include:
• Upstream processing
• Downstream processing and formulation
• Early career researchers • Cell and gene therapy
• Into the future
• Into the clinic

Networking opportunities will be available around the poster and trade exhibition area.

We have a fantastic programme on offer, with keynote presentations from:

Professor Nigel Titchener-Hooker, Executive Dean of the UCL Faculty  of Engineering Sciences, leads the EPSRC Centre for Innovative  Manufacture in Emergent Macromolecular Therapies and was the past lead of the UCL Innovative Manufacturing Research Centre in  Bioprocessing programme. Nigel was elected a Fellow of the Royal  Academy of Engineering in 2008 in recognition of his pioneering work on biopharmaceuticals manufacturing, is a Fellow of the Institution of Chemical Engineers and was awarded the Donald Medal for his contributions to Biochemical Engineering in 2013.

Robert MacLaren is Professor of Ophthalmology at the University of  Oxford, Consultant Ophthalmologist at the Oxford Eye Hospital, Honorary Professor of Ophthalmology at the UCL Institute of Ophthalmology,  Honorary Consultant  Vitreoretinal Surgeon at Moorfields Eye Hospital, Faculty Member and  Founding Theme Leader of the Moorfields-UCL Institute of Ophthalmology  Biomedical Research Centre and an NIHR  Senior Investigator. He is also a  Fellow of the Royal College of Ophthalmologists, Fellow and former King James IV Professor of Surgery  at the Royal College of Surgeons of Edinburgh, Fellow of the Higher Education Academy, Bodley Fellow of Merton College Oxford and Civilian Consultant Advisor to the Royal Navy. He has been a recipient of the ARVO Camras Award for Translational Research, the RP Fighting Blindness Scientist of the Year Award and the Euretina Innovation Award. Together with the University of Oxford in 2014 he co-founded NightstaRx, a biotechnology company based at the Wellcome Trust in London and which has been established to develop further gene therapy treatments for patients with retinal diseases.

Paula M Alves holds a PhD in Biochemical Engineering from Instituto de Tecnologia Quimica Biológica da Universidade Nova de Lisboa. Working in Animal Cell Technology since 1990, her PhD contributed to the establishment of 3D in vitro models of Brain Cells for metabolic trafficking  studies. She is an Independent Researcher and Principal Investigator of  ITQB-New University of Lisbon since 2005. Since January 2007 she is Head of the Animal Cell Technology Unit form ITQB-UNL/IBET. 205 published papers; 29 book chapters; 2 patents. Post-graduation teaching activities at NOVA and at several Portuguese Universities, lecturer at the MIT-Portugal Program. Her Current Research is focused on understanding cell metabolism to improve the efficiency of bioprocesses and at developing new tools and technologies for pre-clinical research, recently expanded to generate expansion and differentiation of stem cells in bioreactors. The Unit she coordinates uses Animal Cell Technology for research and development. She was WP leader in 6 from the 9 EU projects where she participated as PI.


The standard registration fees are outlined below.

Further reductions of an additional £100 are offered to ESACT UK members as detailed below, please e-mail Rhian Carter for the members discount code:

·         Delegate, member: £270 (early bird £220)
·         Delegate, non-member: £370 (early bird £320)

We look forward to hearing from you and thank you in advance for your support – please remember, ESACT UK meetings are organised by scientists for scientists! We are a group of volunteers, so all assistance appreciated!